Research study at Banner MD Anderson Cancer Center tests new drug to fight BRCA-associated breast cancer

GILBERT, Ariz., Aug. 19, 2014 /PRNewswire/ – A cutting-edge research study at Banner MD Anderson Cancer Center is testing the safety and effectiveness of a new investigational drug that, when combined with chemotherapy, may make a major difference in treating breast cancer in patients who carry harmful mutations on either the BRCA1 or BRCA2 genes.  The Brocade Study will enroll patients with …

Canadian Breast Cancer Foundation Announces $7.9 Million Investment in New Research

Canadian Breast Cancer Foundation is excited to be building on its commitment to fund the best and brightest research minds in Canada. Thanks to the overwhelming support of our donors, CBCF-Ontario region …

Research and Markets: Global Cancer Generics (Oral & Injectables) Market Outlook to 2018

Research and Markets has announced the addition of the "Global Cancer Generics Market Outlook 2018" report to thei

VCU Massey Cancer Center receives $4.4 million NCORP grant

( Virginia Commonwealth University ) Virginia Commonwealth University Massey Cancer Center was awarded a $4.4 million, 5-year, renewable grant from the National Cancer Institute to support a statewide network for cancer clinical research in Virginia that brings state-of-the-art clinical trials to patients in their own communities and emphasizes the inclusion of minorities in clinical trials and …

NSAIDs tied to reduced breast cancer recurrence among obese

By Andrew M. Seaman NEW YORK (Reuters Health) – In overweight women, aspirin or other drugs that reduce inflammation might make certain breast cancers more treatable, researchers suggest. Hormone-driven breast cancer was less likely to return in overweight women who regularly used anti-inflammatory medicines, they found. But their findings don't prove the drugs prevent cancer and it's too soon …

Breast Cancer Breakthrough Award funds search for new treatments

( University of California – Santa Cruz ) UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.